Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Targeting Casein Kinase II Exerts a Therapeutic Effect in Pediatric High Risk Leukemia Via Inhibition of Cell Cycle Progression and the PI3K Pathway

Chandrika S. Gowda, MD, Chunhua Song, PhD, Yali Ding, PhD, Sunil Muthusami, MD, Kimberly Payne, PhD, Zheng Ge, Sinisa Dovat, MDPhD

Blood (2015) 126 (23): 4800.

https://doi.org/10.1182/blood.V126.23.4800.4800

Published: 2015

Journal Articles

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia

Chunhua Song, Chandrika Gowda, Xiaokang Pan, Yali Ding, Yongqing Tong, Bi-Hua Tan, Haijun Wang, Sunil Muthusami, Zheng Ge, Mansi Sachdev, Shantu G. Amin, Dhimant Desai, Krishne Gowda, Raghavendra Gowda, Gavin P. Robertson, Hilde Schjerven, Markus Muschen, Kimberly J. Payne, Sinisa Dovat

Blood (2015) 126 (15): 1813–1822.

https://doi.org/10.1182/blood-2015-06-651505

Published: 2015

Includes: Supplemental data

Journal Articles

Epigenetic Regulation of Cell Cycle-Promoting Genes By Ikaros and HDAC1 in Acute Lymphoblastic Leukemia

Sunil Muthusami, MD, Chunhua Song, MD, PhD, Xiaokang Pan, Ph. D., Chandrika S. Gowda, MD, Kimberly J Payne, PhD, Sinisa Dovat, MD,PhD

Blood (2014) 124 (21): 3571.

https://doi.org/10.1182/blood.V124.21.3571.3571

Published: 2014

Journal Articles

Chromatin State Shaping the Gene Expression Profiling in the Inducible Differentiation of Promyelocytic Leukemia Cells

Chunhua Song, MD, PhD, Lisa Chung, PhD, Xiaokang Pan, Ph. D., Li Zhanjun, PhD, Yali Ding, PhD, Mansi Sachdev, MD, Sunil Muthusami, MD, Chandrika S. Gowda, MD, Zheng Ge, MD, PhD, Sadie Steffens, Bi-Hua Tan, MD, PhD, Christina Kendziorski, PhD, Michael Newton, PhD, Sinisa Dovat, MD,PhD

Blood (2014) 124 (21): 5188.

https://doi.org/10.1182/blood.V124.21.5188.5188

Published: 2014

Journal Articles

Restoring Ikaros Function in Leukemia : Casein Kinase II ( CK2) Inhibition Restores Ikaros Tumor Supressor Function and Shows Theraputic Efficacy in Preclinical Models of High Risk Pediatric Leukemia

Chandrika S. Gowda, MD, Chunhua Song, MD, PhD, Sunil Muthusami, MD, Yali Ding, PhD, Mansi Sachdev, MD, Kimberly Payne, PhD, Sinisa Dovat, MDPhD

Blood (2014) 124 (21): 3712.

https://doi.org/10.1182/blood.V124.21.3712.3712

Published: 2014

NARROW

Targeting Casein Kinase II Exerts a Therapeutic Effect in Pediatric High Risk Leukemia Via Inhibition of Cell Cycle Progression and the PI3K Pathway

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia

Epigenetic Regulation of Cell Cycle-Promoting Genes By Ikaros and HDAC1 in Acute Lymphoblastic Leukemia

Chromatin State Shaping the Gene Expression Profiling in the Inducible Differentiation of Promyelocytic Leukemia Cells

Restoring Ikaros Function in Leukemia : Casein Kinase II ( CK2) Inhibition Restores Ikaros Tumor Supressor Function and Shows Theraputic Efficacy in Preclinical Models of High Risk Pediatric Leukemia

Email alerts

ASH Publications

American Society of Hematology

Targeting Casein Kinase II Exerts a Therapeutic Effect in Pediatric High Risk Leukemia Via Inhibition of Cell Cycle Progression and the PI3K Pathway

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia

Epigenetic Regulation of Cell Cycle-Promoting Genes By Ikaros and HDAC1 in Acute Lymphoblastic Leukemia

Chromatin State Shaping the Gene Expression Profiling in the Inducible Differentiation of Promyelocytic Leukemia Cells

Restoring Ikaros Function in Leukemia : Casein Kinase II ( CK2) Inhibition Restores Ikaros Tumor Supressor Function and Shows Theraputic Efficacy in Preclinical Models of High Risk Pediatric Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only